Inventor profile of:

Daniel Cohen

City:

Saint Cloud

Country:

France

Published Applications:

46

Last publication date:

2023-07-27

Top Assignees for applications by Daniel Cohen

The entities that hold a legal rights for patent applications filed by inventor Cohen Daniel:

Recent patent applications by Cohen Daniel

Daniel Cohen from Saint Cloud, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-07-27
US20230233552A1
Human necessities

COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS

#2 | 2021-10-21
US20210322402A1
Human necessities

Compositions for treating CMT and related disorders

#3 | 2021-08-26
US20210260053A1
Human necessities

Early treatment of CMT disease

#4 | 2021-08-05
US20210236445A1
Human necessities

BACLOFEN AND ACAMPROSATE BASED THERAPY OF ALZHEIMER'S DISEASE IN PATIENTS HAVING LOST RESPONSIVENESS TO ACETYLCHOLINESTERASE INHIBITOR THERAPY

#5 | 2021-03-11
US20210069135A1
Human necessities

THERAPEUTIC APPROACHES FOR TREATING EPILEPSY AND RELATED DISORDERS THROUGH REDUCTION OF EPILEPTOGENESIS

#6 | 2020-10-01
US20200306211A1
Human necessities

METHOD FOR ADAPTING DOSES OF COMBINATION THERAPIES

#7 | 2020-07-30
US20200237750A1
Human necessities

Compositions for treating CMT and related disorders

#8 | 2020-07-16
US20200222409A1
Human necessities

COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS BY CONTROLLING BLOOD GLUCOSE LEVEL

#9 | 2020-05-21
US20200155491A1
Human necessities

THERAPEUTIC APPROACHES FOR TREATING CMT AND RELATED DISORDERS

#10 | 2020-04-30
US20200129479A1
Human necessities

Idalopirdine-based combinatorial therapies of Alzheimer's disease

#11 | 2020-03-19
US20200085790A1
Human necessities

BACLOFEN AND ACAMPROSATE BASED THERAPY OF NEUROLOGICAL DISORDERS

#12 | 2020-01-30
US20200030314A1
Human necessities

Early treatment of CMT disease

#13 | 2019-06-13
US20190175568A1
Human necessities

Compositions for treating amyotrophic lateral sclerosis

#14 | 2019-04-18
US20190111054A1
Human necessities

Combinatorial therapies of neurological disorders

#15 | 2019-01-10
US20190008841A1
Human necessities

Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level

#16 | 2018-12-20
US20180360785A1
Human necessities

Therapeutic approaches for treating CMT and related disorders

#17 | 2018-12-06
US20180344711A1
Human necessities

Compositions for treating amyotrophic lateral sclerosis

#18 | 2018-11-29
US20180338988A1
Human necessities

Compositions for treating neurological disorders

#19 | 2018-11-29
US20180338969A1
Human necessities

Therapeutic approaches for treating CMT and related disorders

#20 | 2018-09-27
US20180275144A1
Physics

DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE

#21 | 2018-09-20
US20180263989A1
Human necessities

THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE

#22 | 2018-09-06
US20180250290A1
Human necessities

Compositions for treating CMT and related disorders

#23 | 2018-09-06
US20180250289A1
Human necessities

Therapeutic approaches for treating CMT and related disorders

#24 | 2018-07-26
US20180209997A1
Physics

DIAGNOSTIC TOOLS FOR CHARCOT-MARIE-TOOTH DISEASE

#25 | 2018-05-10
US20180125867A1
Human necessities

COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS

#26 | 2018-04-05
US20180092890A1
Human necessities

Nootropic compositions for improving memory performance

#27 | 2018-01-04
US20180000813A1
Human necessities

Early treatment of CMT disease

#28 | 2017-09-28
US20170273919A1
Human necessities

Therapeutic approaches for treating Parkinson's disease

#29 | 2017-08-17
US20170231958A1
Human necessities

BACLOFEN AND ACAMPROSATE BASED THERAPY OF NEUROLOGICAL DISORDERS

#30 | 2017-06-15
US20170165256A1
Human necessities

Compositions for treating CMT and related disorders

#31 | 2017-02-23
US20170049777A1
Human necessities

COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETIC NEUROPATHIES

#32 | 2016-12-08
US20160354362A1
Human necessities

Compositions for treating CMT and related disorders

#33 | 2016-12-08
US20160354335A1
Human necessities

Combination of baclofen, acamprosate and medium chain triglycerides for the treatment of neurological disorders

#34 | 2016-08-18
US20160235693A1
Human necessities

Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level

#35 | 2016-07-21
US20160206603A1
Human necessities

Composition comprising torasemide and baclofen for treating neurological disorders

#36 | 2016-07-07
US20160195547A1
Physics

DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE

#37 | 2016-07-07
US20160193163A1
Human necessities

Therapeutic approaches for treating Parkinson's disease

#38 | 2016-05-19
US20160136143A1
Human necessities

Compositions for treating amyotrophic lateral sclerosis

#39 | 2016-01-07
US20160000736A1
Human necessities

Baclofen and acamprosate based therapy of neurological disorders

#40 | 2015-12-31
US20150374647A1
Human necessities

THERAPEUTIC APPROACHES FOR TREATING EPILEPSY AND RELATED DISORDERS THROUGH REDUCTION OF EPILEPTOGENESIS

#41 | 2015-10-22
US20150301069A1
Physics

Diagnostic tools for charcot-marie-tooth disease

#42 | 2015-09-03
US20150246044A1
Human necessities

Therapeutic approaches for treating Parkinson's disease

#43 | 2015-08-27
US20150238452A1
Human necessities

Baclofen and acamprosate based therapy of macular degeneration disorders

#44 | 2015-08-20
US20150231123A1
Human necessities

Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level

#45 | 2015-08-13
US20150224092A1
Human necessities

Nootropic compositions for improving memory performance

#46 | 2014-12-04
US20140357648A1
Human necessities

Therapeutic approaches for treating Alzheimer's disease

InventorID:

1253030 ⎘